Effect of enhanced external counterpulsation treatment on mean platelet volume in patients affected by ischemic chronic heart failure

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 2, 2012, Pages 127-131

  Ertaş, Gökhan ^a   Kozdaǧ, Güliz ^b   Emre, Ender ^b   Akay, Yaşar ^b   Ural, Dilek ^b   Hebert, Kathy ^c  

^a Psychiatry Clinic Gümü hane State Hospital   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

chronic heart failure; enhanced external counterpulsation; mean platelet volume; platelet

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COUNTERPULSATION; EXTERNAL COUNTERPULSATION TREATMENT; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CHRONIC DISEASE; COUNTERPULSATION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET COUNT; TREATMENT OUTCOME;

EID: 84856610710     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834ee144     Document Type: Article

References (20)

1. Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002; 39:459-497. (Pubitemid 35176969)
2. Park Y, Schoene N, Harris W. Mean platelet volume is an indicator of platelet activation: methodological issues. Platelets 2002; 13:301-306. (Pubitemid 34864514)
3. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17:47-58.
4. Trip MD, Cats VK, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. New Engl J Med 1990; 322:1549-1554. (Pubitemid 20176694)
5. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after MI. Lancet 1991; 338:1409-1411.
6. Kandis H, Ozhan H, Ordu S, Erden I, Caglar O, Basar C, et al. The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J 2011; 28:575-578.
7. Alper AT, Akyol A, Hasdemir H, Yildirim A, Nurkalem Z, Gü venç TS, et al. Effect of cardiac resynchronization therapy on mean platelet volume. Acta Cardiol 2008; 63:735-739.
8. Soran O, Kennard ED, Holubkov R, Strobeck J, Feldman AM. Six month outcome of patients with left ventricular dysfunction treated with enhanced external counterpulsation for chronic angina [abstract]. Eur Heart J 2000; 21:598.
9. Soran OZ, Fleishman B, Demarco T, Grossman V, Schneider VM, Manzo K, et al. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002; 8:204-209.
10. Soran O, Crawford LE, Schneider VM, Feldman AM. Enhanced external counterpulsation in the management of patients with cardiovascular disease. Clin Cardiol 1999; 22:173-178. (Pubitemid 29116165)
11. Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999; 101:140-144. (Pubitemid 29243755)
12. Huczek Z, Filipiak KJ, Kochman J, Michalak M, Roik M, Piatkowski R, et al. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thromb Res 2010; 125:406-412.
13. Schiller NB, Shah PM, CrawfordM,DeMaria A, Devereux R,Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
14. Thompson CB, Diaz DD, Quinn PG, Lapins M, Kurtz SR, Valeri CR. The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol 1983; 80:327-332. (Pubitemid 13048994)
15. Feldman AM, Silver MA, Francis GS, Abbottsmith CW, Fleishman BL, Soran O, et al. PEECH Investigators. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2006; 48:1198-1205. (Pubitemid 44345118)
16. Kiernan TJ, Boilson BA, Tesmer L, Harbuzariu A, Simari RD, Barsness GW. Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets. Int J Cardiol 2010; 153:202-206.
17. Taguchi I, Ogawa K, Kanaya T, Matsuda R, Kuga H, Nakatsugawa M. Effects of enhanced external counterpulsation on hemodynamics and its mechanism relation to neurohumoral factors. Circ J 2004; 68:1030-1034. (Pubitemid 39540133)
18. Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, et al. Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 2010; 12:676-684.
19. Iversen PO, Woldbaek PR, Tønnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 2002; 282:R166-R172. (Pubitemid 34663923)
20. Gasparyan AY. Aspirin and clopidogrel resistance: methodological challenges and opportunities. Vasc Health Risk Manag 2010; 6:109-112.